Protara Therapeutics, Inc. Marketable Securities (Current)
Protara Therapeutics, Inc. (TARA) had Marketable Securities (Current) of $125.42 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-11
- 2026-06-30: Marketable Securities, Current $125.42M.
- 2026-03-31: Marketable Securities, Current $121.05M.
- 2025-12-31: Marketable Securities, Current $105.90M.
- 2025-09-30: Marketable Securities, Current $120.12M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $125.42M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $121.05M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $105.90M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $120.12M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $90.72M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $32.90M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.49M 10-K · filed 2026-03-10 |
| 2024-09-30 | $29.74M 10-Q · filed 2024-11-12 |
| 2024-03-31 | $2.99M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $25.99M 10-K · filed 2025-03-05 |
| 2023-09-30 | $40.27M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $46.38M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $65.58M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $60.24M 10-K · filed 2024-03-13 |
| 2022-09-30 | $48.82M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $64.64M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $62.16M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $55.51M 10-K · filed 2023-03-08 |
| 2021-09-30 | $53.02M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $37.83M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $26.14M 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |